The Leukemia & Lymphoma Society (LLS) is a non-profit organization focused on finding a cure for blood cancer and providing their patients with the medical care available. For 65 years, the LLS has been an advocate for blood cancer patients, families, and survivors. In honor of September, Blood Cancer Awareness Month LLS has developed 30 “proof points”, one for each day of the month that displays the organizations success and impact towards finding a cure for blood cancer. With more than $1 billion invested in treatments and research, LLS hopes to reach their goal of $400,000 during Blood Cancer Awareness Month to continue their efforts in creating a world without blood cancer.
Leukemia is “a malignant progressive disease in which the bone marrow and other blood-forming organs produce increased numbers of immature or abnormal leukocytes. These suppress the production of normal blood cells, leading to anemia and other symptoms.”An estimated combined total of 162,020 people in the U.S. are expected to be diagnosed with leukemia, 60,192 people die, 14% live in remission and my father is just another statistic. When I was nine years old, my father was diagnosed with Leukemia, an illness that at the time I did not understand. This left my mother raising two kids and working two jobs to make ends meet. Throughout this time of never ending hospital visits, I experienced the kindness and care provided to us by my father’s doctors - something that until this day I will never forget.
Transition: Now that I have talked about the basics regarding Acute Lymphoblastic Leukemia, let’s talk about the new approaches we are taking to combat this disease.
The nonprofit Leukemia and Lymphoma society came about from the sorrow of a couple whose son lost his life in 1944. His name was RobbieRobert Roesler de Villiers, part of a well-off family based in New York. Leukemia was the cause of his death at the early age of 16. Following their son’s death, his parents, Rudolph and Antoinette, began an organization in 1949 under his name. The product of their efforts was run out of a Wall Street office, consisting of a small team of devoted volunteers. During this time leukemia had a 100% fatality rate as of 1955, with most patients with the disease losing their lives within a period of three months. The de Villiers’ held a resounding work ethic and belief that blood cancers were curable, and so the Foundation saw consistent growth. When the year 1960 came about the organization was rebranded as The Leukemia Society of America in order to extend its horizons.
To travel from my home in Ocoee to the main campus of the University of Central Florida is about a thirty minute drive. Travelling to the Moffitt Cancer Center in Tampa takes about an hour and a half or two hours max. The journey through the diagnoses, four chemo treatments, and being involved in a clinical trial that may or may cure Acute Myeloid Leukemia has taken one year, one month, and ten days and counting. I regard this past year as the building of true endurance and perseverance of hope and good spirits. It has been a truly humbling journey as well, experiencing first hand the sacrifice of supporting a loved one with leukemia.
Researchers at Rockefeller University have a lead on a new cure for acute myeloid leukemia, a rare form of cancer. This form of cancer starts in the bone marrow, which is a flatty substance inside the bones where blood cells are produced. The cancerous cells then travels with the blood cells into the circulatory system, which causes the cancer cells to spread to the rest of the body. The cancer causes less blood cells to be present thus causing the body to lack blood cells which fight infections and carries vital compounds such as oxygen. The lack of oxygen does not affect the cancer cells, as most cancers cells create most of their energy without the presence of oxygen. Scientist are looking at a mutations in the cell, especially regarding to DNA rearrangement, to see if they can find a ‘loophole’ to cure this strain of cancer. This causes the scientists to
Acute myeloid leukemia (AML) is characterized by an increase in the number of myeloid cells in the marrow and an arrest in their maturation.(1) Make sure you use the ASM system for reference citation; I do not believe this format you have is correct. The symptoms of AML are caused by the replacement of normal bone marrow with leukemic cells, which causes a drop in red blood cells, platelets, and normal white blood cells.(2) These symptoms include fatigue, shortness of breath, easy bruising and bleeding, and increased risk of infection.(1) Several risk factors and chromosomal abnormalities have been identified. AML progresses rapidly and is typically fatal within weeks or months if left untreated. This disease is a heterogeneous clonal disorder of haemopoietic progenitor cells.(2) These cells lose the ability to differentiate normally and to respond to normal regulators of proliferation.(2) AML has a terrible prognosis, with only 23.8% of patients surviving five years after diagnosis. (3) AML is treated initially with chemotherapy aimed at inducing a remission; patients may go on to receive additional chemotherapy or a hematopoietic stem cell transplant. The majority of patients, despite reaching complete remission with classical chemotherapy, will relapse.(3) The persistence of malignant cells is what causes remission. (3) Acute myeloid leukemia affects both older and younger patients. However, most patients are older than 60 years old, and the prognosis is worse for
Acute Lymphocytic Leukemia is a scary disease. The term “acute” means the disease can quickly spread and progress quickly and can prove fatal in months if left untreated. “Lymphocytic” simply means that it develops from immature forms of lymphocytes. Also known as Acute Lymphoblastic Leukemia, or ALL for short, it is a type of cancer that starts from the early form of white blood cells called lymphocytes in the bone marrow. ALL is the most common form of cancer in children, though adults can get it as well. For children, treatment results in a good chance of a cure. Adults have a significantly smaller chance of a cure with ALL. ALL generally invades the blood very quickly and has the potential to spread to other body parts such as the spleen,
Chemotherapy is the main way of treating AML.It is divided into three phase, Induction chemotherapy, Post-remission chemotherapy and Consolidation chemotherapy.Alone a chemotherapy is not that much effective so a Stem cell transplantation or a Bone marrow Transplantation is recommended (only if the patients is able to tolerate a transplantation) in most of the times. Allogeneic (ALLO) stem cell transplantation (i.e. using donated stem cell)is done in case of patients suffering from AML. This induction chemotherapy is given with (except in case of M3 subtype of AML) cytarabine (ara-C) and an anthracycline . The induction Chemotherapy routine is also denoted by “7+3” because the cytarabine is given to the patients continuous IV infusions for 7 days consecutively and as
After their successful work with Acute Lymphoblastic Leukemia, St. Jude Children’s Hospital decided to expand their efforts outwards and focus on another type of leukemia that attacks the lives of children every year. Acute Myeloid Leukemia, a cancer that begins in bone marrow and quickly multiplies and spreads to white blood cells, makes up 20% of all childhood leukemia (Pui 51). The first AML study at St. Jude began in 1986. Before the start of this project, only one child out of every 58 children suffering from this illness survived for a time greater than five years; however, by the end of the first study completed in 1973, the rate of remission had increased to 66%. Although St. Jude was ecstatic that they had brought the rate of remission
Leukemia is something that we hear about a lot. I believe that people do not understand exactly what leukemia is and how dangerous it can be, I chose this topic to try to help them understand. In this paper I will explain what leukemia is and what treatments you can choose from to treat the cancer.
Cancer is one of the most feared diseases, and it can affect all parts of the body, including the blood. Leukemia and lymphoma are both blood cancers. Leukemia and Lymphoma have serval things in common. First, both are result from problems with white blood cells. “In leukemia, bone marrow produces too many white blood cells that do not naturally die off in the method that usual aging blood cells do”.  “Lymphoma is a kind of blood cancer that affects your lymphatic system, an important part of your immune system, which helps to protect your body from infection and disease” . Lymphoma frequently begin in the lymph nodes, which are slight tissues that support in your body’s fight against infection.  Certain kinds of lymphoma also may
Jack woke up one morning not feeling well. He felt very weak and could not get out of bed. His mother decided to take him to the doctors. The doctors took many tests to figure out what was making him feel that way. After about an hour or two the doctors got the results back from a blood test. Results that would change Jack’s childhood for the worse. Jack has been diagnosed with Leukemia, a blood cancer. Of course, Jack was not sure what that meant but, his parents became worried beyond belief with the long road ahead of them. Scientists and researchers were all involved in the discovery of Leukemia cancer, which increased knowledge of this cancer, decreased deaths and discovered treatments, and started charity groups to fund research.